As of Nov 19, 2026, 0 of 1 active firms rate PHG a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PHG EPS & revenue forecast
EPS · NEXT QUARTER
$0.23
Range $0.23 – $0.23 · 1 analysts · -16% YoY
Next period, 1 analysts expect Koninklijke Philips NV ADR to earn $0.23 a share (range $0.23 – $0.23), versus $0.27 a year earlier. Full-year consensus is $1.89, growing to $2.04 the year after.
REVENUE · NEXT QUARTER
$4.0B
Range $3.8B – $4.2B · 1 analysts · +3% YoY
Revenue is expected to reach $4.0B (range $3.8B – $4.2B), +3.2% year-over-year. Full-year consensus is $18.0B, rising to $18.9B next year.
Top analysts covering Koninklijke Philips NV ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PHG.
#1
GD
Graham Doyle
UBS
Neutral
No targeton PHG
Coverage
—
+ Follow
#2
LB
Lisa Bedell Clive
Bernstein
Buy
$30.30+1.6% to target
Coverage
—
+ Follow
#3
JO
Julien Ouaddour
B of A Securities
Neutral
No targeton PHG
Coverage
—
+ Follow
PHG stock forecast FAQ
Is PHG stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover PHG?+
1 active firms have a recognized rating on Koninklijke Philips NV ADR as of Nov 19, 2026.
Who is the most accurate analyst covering PHG?+
Among analysts who currently cover PHG, Graham Doyle of UBS has the strongest overall Quantellect track record. Their current call is Neutral.
What is Koninklijke Philips NV ADR's projected EPS for next quarter?+
The consensus estimate is $0.23 per share (range $0.23 – $0.23) across 1 analysts. Full-year EPS is projected at $1.89, rising to $2.04 the following year.
How much revenue is Koninklijke Philips NV ADR expected to report next quarter?+
Consensus revenue is $4.0B (range $3.8B – $4.2B). Full-year revenue is projected at $18.0B, growing to $18.9B next year.
Have analysts been upgrading or downgrading PHG lately?+
As of Nov 19, 2026, 0 of 1 active firms rate PHG a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PHG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.